Description
| Product Name | Format | CAT.No | Size |
| CK-nac Nac Activation Serum Start, IFCC | Lyo | BXC0251B | R1: 1 x 105ml R2: 10 x 10ml |
| CK-nac Nac Activation Serum Start, IFCC | Lyo | BXC0251D | R1: 1 x 35ml R2: 10 x 2.5ml |
| CK-nac Nac Activation Serum Start, DGKC | LS | BXC0252A | R1: 2 x 25ml R2: 2 x 5ml |
| CK-nac Nac Activation Serum Start, DGKC | LS | BXC0252B | R1: 2 x 50ml R2: 2 x 10ml |
| CK-nac Nac Activation Serum Start, DGKC | LS | BXC0252C | R1: 6 x 10ml R2: 1 x 12ml |
| CK-nac 4+1 Nac Activation Serum Start, DGKC | LS | BXC0253A | R1: 2 x 20ml R2: 1 x 10ml |
| CK-nac 4+1 Nac Activation Serum Start, DGKC | LS | BXC0253B | R1: 2 x 40ml R2: 1 x 20ml |
Product Description
The Biorex Diagnostics CK-NAC Assay is a ready-to-use reagent system for the quantitative determination of total creatine kinase (CK) activity in human serum or plasma. CK-NAC testing is a clinically important tool for diagnosing myocardial ischaemia, acute myocardial infarction, and skeletal muscle injury.
Key Features
• Quantitative measurement of total CK activity in serum and plasma
• Clinically relevant for cardiac events, skeletal muscle disorders, and tissue injury assessment
• NAC-activated IFCC enzymatic method ensures high accuracy, sensitivity, and reproducibility
• Ready-to-use reagents simplify laboratory workflow and reduce preparation errors
• Compatible with automated analysers, kinetic assays, and manual laboratory methods
Benefits
The Biorex CK-NAC Assay provides precise and reliable results for cardiac and muscle injury evaluation, clinical research, and routine enzyme testing. Its ready-to-use format and robust methodology streamline laboratory workflows while delivering essential information for effective patient diagnosis, monitoring, and management.